Well-Being Therapy for Depressive Symptoms in Chronic Migraine: A Case Report

Abstract

Depression in chronic migraine is a common and vexing problem. Stress-oriented psychotherapies showed to improve depressive symptoms but not to affect migraine disability or attacks. Well-Being Therapy (WBT) is a short-term psychotherapy intervention based on promoting well-being and optimizing functioning, which showed to be effective in the treatment of residual depressive symptoms and chronic pain. This single case describes an account of successful WBT for a case of chronic migraine with depressive symptoms. The patient is a 37-year old employed, engaged, Caucasian heterosexual woman who had chronic migraine without aura and depressive symptoms and received eight WBT sessions. Number of migraine attacks, migraine disability, and psychological variables were assessed at baseline, at sessions 4 and 8 of WBT, and at 3-month follow-up. At session 8 of WBT, a decrease in number of migraine attacks and migraine disability was observed together with an improvement on depressive symptoms as well as an increase of well-being and euthymia. The positive effects of WBT were maintained at 3-month follow-up. WBT may be a promising intervention for chronic migraine patients with depressive symptoms.

Keywords

psychological well-being depression well-being therapy chronic migraine

Get full access to this article

View all access options for this article.

References

Araki

Takeshima

Ando

Iizuka

Igarashi

Ikeda

Ito

Inagaki

Imamura

Ohkuma

Ogawa

Watanabe

Kato

Kikui

Kitamura

Kudo

Kuwabara

Gono

Kowa

. . . Watanabe

. (2019). Clinical practice guideline for chronic headache 2013. Neurology and Clinical Neuroscience, 7(5), 231–259. https://doi.org/10.1111/ncn3.12322

Bech

Gudex

Johansen

K. S.

(1996). The WHO (ten) well-being index: Validation in diabetes. Psychotherapy and Psychosomatic, 65(4), 183–190. https://doi.org/10.1159/000289073.

Becker

W. J.

(2017). The diagnosis and management of chronic migraine in primary care. Headache: The Journal of Head and Face Pain, 57(9), 1471–1481. https://doi.org/10.1111/head.13089.

Bigal

M. E.

Lipton

R. B.

(2009). The epidemiology, burden, and comorbidities of migraine. Neurologic Clinics, 27(2), 321–334. https://doi.org/10.1016/j.ncl.2008.11.011

Buse

D. C.

Manack

Serrano

Turkel

Lipton

R. B.

(2010). Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. Journal of Neurology, Neurosurgery and Psychiatry, 81(4), 428–432. https://doi.org/10.1136/jnnp.2009.192492.

Burch

R. C.

Buse

D. C.

Lipton

R. B.

(2019). Migraine: Epidemiology, burden, and comorbidity. Neurologic Clinics, 37(4), 631–649. https://doi.org/10.1016/j.ncl.2019.06.001.

Carrozzino

Svicher

Patierno

Berrocal

Cosci

(2019). The euthymia scale: A clinimetric analysis. Psychotherapy and Psychosomatic, 88(2), 119–121. https://doi.org/10.1159/000496230

Cecchini

A. P.

Leone

Manzoni

G. C.

Torelli

Bussone

(2012). Drug-resistant chronic migraine: The Italian GON project. Neurological Sciences, 33(1), 33–35. https://doi.org/10.1007/s10072-012-1028-7

Condello

Piano

Dadam

Pinessi

Lantéri-Minet

(2015). Pain beliefs and perceptions inventory: A cross-sectional study in chronic and episodic migraine. Headache: The Journal of Head and Face Pain, 55(1), 136–148. https://doi.org/10.1111/head.12503.

10.

Cosci

. (2015). Well-being therapy in a patient with panic disorder who failed to respond to paroxetine and cognitive behavior therapy. Psychotherapy and Psychosomatic, 84(5), 318–319. https://doi.org/10.1159/000430789.

11.

Cosci

Fava

G. A.

(2013). Staging of mental disorders: Stematic review. Psychotherapy and Psychosomatic, 82(1), 20–34. https://doi.org/10.1159/000342243.

12.

Cosci

Svicher

Mansueto

Benemei

Chiarugi

De Cesaris

Guidi

Zipfel

(2020). Mental pain and pain-proneness in patients with migraine: Results from the PAINMIG cohort-study. CNS Spectrums, 1–10. https://doi.org/10.1017/S1092852920001480

13.

Csikszentmihalyi

I. S.

(Eds.) (1988). Optimal experiences. Psychological studies of flow of consciousness. Cambridge University Press.

14.

D’amico

Mosconi

Genco

Usai

Prudenzano

A. M. P.

Grazzi

Leone

Puca

F. M.

Bussone

(2001). The Migraine Disability Assessment (MIDAS) questionnaire: Translation and reliability of the Italian version. Cephalalgia, 21(10), 947–952. https://doi.org/10.1046/j.0333-1024.2001.00277.x.

15.

Dresler

Caratozzolo

Guldolf

Huhn

J. I.

Loiacono

Niiberg-Pikksööt

Puma

Sforza

Tobia

Ornello

Serafini

(2019). Understanding the nature of psychiatric comorbidity in migraine: A systematic review focused on interactions and treatment implications. The Journal of Headache and Pain, 20(1), 51. https://doi.org/10.1186/s10194-019-0988-x

16.

Dindo

L. N.

Recober

Calarge

C. A.

Zimmerman

B. M.

Weinrib

Marchman

J. N.

Turvey

(2020). One-day acceptance and commitment therapy compared to support for depressed migraine patients: A randomized clinical trial. Neurotherapeutics, 17(2), 743–753. https://doi.org/10.1007/s13311-019-00818-0.

17.

Fava

G. A.

(2016a). Well-being therapy, treatment manual and clinical applications. Karger Publishers. https://doi.org/10.1159/isbn.978-3-318-05822-2.

18.

Fava

G. A.

(2016b). Well-being therapy: Current indications and emerging perspectives. Psychotherapy and Psychosomatic, 85(3), 136–145. https://doi.org/10.1159/000444114

19.

Fava

G. A.

Bech

(2016). The concept of euthymia. Psychotherapy and Psychosomatic, 85(1), 1–5. https://doi.org/10.1159/000441244

20.

Fava

G. A.

Cosci

Guidi

Tomba

(2017). Well-being therapy in depression: New insights into the role of psychological well-being in the clinical process. ‎Depression & Anxiety, 34(9), 801–808. https://doi.org/10.1002/da.22629

21.

Fava

G. A.

Guidi

(2020). The pursuit of euthymia. World Psychiatry, 19(1), 40–50. https://doi.org/10.1002/wps.20698

22.

Fava

G. A.

Kellner

Perini

G. I.

Fava

Michelacci

Munari

Evangelisti

L. P.

Grandi

Bernardi

Mastrogiacomo

(1983). Italian validation of the symptom rating test (SRT) and symptom questionnaire (SQ). Canadian Journal of Psychiatry, 28(2), 117–123. https://doi.org/10.1177/070674378302800208

23.

Fava

G. A.

Rafanelli

Grandi

Conti

Belluardo

(1998). Prevention of recurrent depression with cognitive behavioral therapy: Preliminary findings. Archives of General Psychiatry, 55(9), 816–820. https://doi.org/10.1001/archpsyc.55.9.816.

24.

Fava

G. A.

Ruini

Rafanelli

Finos

Salmaso

Mangelli

Sirigatti

(2005). Well-being therapy of generalized anxiety disorder. Psychotherapy and Psychosomatics, 74, 26–30. https://doi.org/10.1159/000082023.

25.

Fordyce

W. E.

(1976). Behavioral methods for chronic pain and illness. Mosby.

26.

GBD 2010 Country Collaboration. (2013). GBD 2010 country results: A global public good. Lancet, 381(9871), 965–970. https://doi.org/10.1016/S0140-6736(13)60283-4.

27.

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990– 2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388(10053), 1545–1602. https://doi.org/10.1016/S0140-6736(16)31678-6.

28.

GBD 2016 Headache Collaborators. (2018). Global, regional, and national burden of migraine and tension-type headache, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 17(11), 954–976. https://doi.org/10.1016/S1474-4422(18)30322-3.

29.

Hooten

M. W.

(2016). Chronic pain and mental health disorders: Shared neural mechanisms, epidemiology, and treatment. Mayo Clinic Proceedings, 91(7), 955–970. https://doi.org/10.1016/j.mayocp.2016.04.029.

30.

Jahoda

(1958). Current Concepts of Positive Mental Health. New York: Basic Books.

31.

Jensen

M. P.

(2002). Enhancing motivation to change in pain treatment. In: Turk

Gatchel

, eds. Psychological approaches to pain management: A practitioner’s handbook (pp. 71–93). Guilford Publications.

32.

Jensen

M. P.

Devlin

H. C.

Vowles

K. E.

Molton

I. R.

(2019). Assessing perceived success in valued living in individuals with long-term physical health conditions. Journal of Aging and Health, 31(10), 195S–213S. https://doi.org/10.1177/0898264319861006.

33.

Jensen

M. P.

Vowles

K. E.

Johnson

L. E.

Gertz

K. J.

(2015). Living well with pain: Development and preliminary evaluation of the valued living scale. Pain Medicine, 16(11), 2109–2120. https://doi.org/10.1111/pme.12802.

34.

International Headache Society. (2018). The international classification of headache disorders, 3rd edition. Cephalalgia, 38(1), 1–211. https://doi.org/10.1177/0333102417738202.

35.

Kellner

(1972). Improvement criteria in drug trials with neurotic patients. Part 2. Psychological Medicine, 2, 73–80. https://doi.org/10.1017/s0033291700045645

36.

Kellner

(1987). A symptom questionnaire. Journal of Clinical Psychiatry, 48(7), 268–274.

37.

Knowlton

C. N.

Kryvanos

Poole

Christopher

Lafavor

(2019). Acceptance and commitment therapy for the treatment of chronic pain and coexisting depression: A single-case study. Clinical Case Studies, 18(4), 254–269. https://doi.org/10.1177/1534650119839156

38.

Leonardi

Raggi

(2019). A narrative review on the burden of migraine: When the burden is the impact on people’s life. The Journal of Headache and Pain, 20(1), 41. https://doi.org/10.1186/s10194-019-0993-0

39.

Lipton

R. B.

Stewart

W. F.

Sawyer

Edmeads

J. G.

(2001). Clinical utility of an instrument assessing migraine disability: The Migraine Disability Assessment (MIDAS) questionnaire. Headache: The Journal of Head and Face Pain, 41(9), 854–861. https://doi.org/10.1111/j.1526-4610.2001.01156.x

40.

Manack

A. N.

Buse

D. C.

Lipton

R. B.

(2011). Chronic migraine: Epidemiology and disease burden. Current Pain and Headache Reports, 15(1), 70–78. https://doi.org/10.1007/s11916-010-0157-z

41.

Mansueto

De Cesaris

Geppetti

Cosci

(2018). Protocol and methods for testing the efficacy of well-being therapy in chronic migraine patients: A randomized controlled trial. Trials, 19(1), 561. https://doi.org/10.1186/s13063-018-2944-5

42.

Martin

P. R.

Aiello

Gilson

Meadows

Milgrom

Reece

(2015). Cognitive behavior therapy for comorbid migraine and/or tension-type headache and major depressive disorder: An exploratory randomized controlled trial. Behaviour Research and Therapy, 73, 8–18. https://doi.org/10.1016/j.brat.2015.07.005

43.

May

Schulte

L. H.

(2016). Chronic migraine: Risk factors, mechanisms and treatment. Nature Reviews Neurology, 12(8), 455–464. https://doi.org/10.1038/nrneurol.2016.93

44.

Meulenbeek

Christenhusz

Bohlmeijer

(2015). Well-being therapy in the Netherlands. Psychotherapy and Psychosomatics, 84, 316–317. https://doi.org/10.1159/000381552.

45.

Mohr

D. C.

Hart

S. L.

Howard

Julian

Vella

Catledge

Feldman

M. D.

(2006). Barriers to psychotherapy among depressed and nondepressed primary care patients. Annals of Behavioral Medicine, 32(3), 254–258. https://doi.org/10.1207/s15324796abm3203_12.

46.

National Institute for Health and Care Excellence. (2015). Headaches in over 12s: Diagnosis and management. National Institute for Health and Care Excellence.

47.

Olesen

Bousser

M. G.

Diener

H. C.

Dodick

First

Goadsby

P. J.

Göbel

Lainez

M. J. A.

Lance

J. W.

Lipton

R. B.

Nappi

Sakai

Schoenen

Silberstein

S. D.

Steiner

T. J.

(2006). Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia, 26(6), 742–746.https://doi.org/10.1111/j.1468-2982.2006.01172.x.

48.

Piolanti

Offidani

Guidi

Gostoli

Fava

G. A.

Sonino

(2016). Use of the psychosocial index: A sensitive tool in research and practice. Psychotherapy and Psychosomatic, 85(6), 337–345. https://doi.org/10.1159/000447760

49.

Ryff

C. D.

(2014). Psychological well-being revisited: Advances in the science and practice of eudaimonia Psychotherapy and Psychosomatic, 83, 10–28. https://doi.org/10.1159/000353263.

50.

Rotterman

Wright

J. H.

(2019). Well-being therapy for recurrent depression and chronic pain. Psychotherapy and Psychosomatic, 88(6), 378–379. https://doi.org/10.1159/000502848

51.

Ruini

Ottolini

Rafanelli

Ryff

C. D.

Fava

G. A.

(2003). La validazione italiana delle Psychological Well-being Scales (PWB). Rivista di psichiatria, 38(3), 117–130. https://doi.org/10.1708/173.1864

52.

Ryff

C. D.

Keyes

(1995). The structure of psychological well-being revisited. Journal of Personality and Social Psycholy, 69(4),719–727. https://doi.org/10.1037/0022-3514.69.4.719

53.

Sharpe

Dudeney

Williams

A. C. C.

Nicholas

McPhee

Baillie

Welgampola

McGuire

(2019). Psychological therapies for the prevention of migraine in adults. Cochrane Database Systematic Review, 7(7). https://doi.org/10.1002/14651858.CD012295.pub2

54.

Sheehan

D. V.

Lecrubier

Sheehan

K. H.

Amorim

Janavs

Weiller

Hergueta

Dunbar

G. C.

(1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.) the development and validation of a structured diagnostic interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59(Suppl 20), 22–33.

55.

Sonino

Fava

G. A.

(1998). A simple instrument for assessing stress in clinical practice. Postgraduate Medical Journal, 74(873), 408–410. https://doi.org/10.1136/pgmj.74.873.408

56.

Topcu

S. Y.

(2018). Relations among pain, pain beliefs, and psychological well-being in patients with chronic pain. Pain Management Nursing, 19(6), 637–644. https://doi.org/10.1016/j.pmn.2018.07.007.

57.

Wells

R. E.

Seng

E. K.

Edwards

R. R.

Victorson

D. E.

Pierce

C. R.

Rosenberg

Napadow

Schuman-Olivier

(2020). Mindfulness in migraine: A narrative review. Expert Review of Neurotherapeutics, 20(3), 207–225. https://doi.org/10.1080/14737175.2020.1715212.

58.

Whiteford

H. A.

Harris

M. G.

McKeon

Baxter

Pennell

Barendregt

J. J.

Wang

(2013). Estimating remission from untreated major depression: A systematic review and meta-analysis. Psychological medicine, 43(8), 1569-1585. https://doi.org/10.1017/S0033291712001717.

59.

WHO. (1948). Constitution. Geneva: World Health Organization.